Dozee, a Bengaluru-based healthtech startup, is set to secure $10 million (approximately ₹86 crore) in debt funding from Stockhausen International Pte Ltd, marking its second debt infusion within four months following a $7 million raise in March.
Key Highlights
- Dozee secures $10M debt funding from Stockhausen International, four months after previous $7M infusion.
- Funds will be used to scale operations, support subsidiaries outside India, and drive business development.
According to regulatory filings with the Registrar of Companies (RoC), Dozee’s board has approved the issuance of 7,545 Series B optionally convertible debentures at a face value of ₹1,14,074 each to raise the fresh capital. The company stated that the funds will be directed towards strengthening business operations, product development, and extending loans to its overseas subsidiaries.
Founded in 2015, Dozee develops remote health monitoring and early warning solutions. Its flagship offerings include Shravan, an AI-powered hearing screening and rehabilitation device, and a contactless smart mat that tracks heart rate, respiration, stress levels, and sleep patterns. Recently, Dozee received the CE Mark certification under EU MDR 2017/745, underscoring compliance with global medical device safety and efficacy standards.
Also Read: Arintra Secures $21M Series A funding Round from Peak XV Partners
The Prime Venture Partners-backed startup has raised nearly $38 million to date, both in equity and debt, from investors such as Yournest, 3One4 Capital, and Prime Venture Partners, according to data platform TheKredible. In FY24, Dozee posted an operating revenue of ₹5 crore while narrowing its losses by 20% to ₹68 crore from ₹84.4 crore in FY23. FY25 financial results are yet to be disclosed.
Dozee is emerging as a key player in India’s rapidly growing Remote Patient Monitoring (RPM) and Early Warning Systems (EWS) segment, leveraging AI-driven solutions to enhance hospital and home healthcare delivery.
